NCT04792970View on ClinicalTrials.gov

Randomized Controlled Trial of Talc Instillation In Addition To Daily Drainage Through a Tunneled Pleural Catheter to Improve Rates of Outpatient Pleurodesis in Patients With Malignant Pleural Effusion

PHASE4TerminatedINTERVENTIONAL
Enrollment

4

Participants

Timeline

Start Date

March 18, 2021

Primary Completion Date

October 7, 2022

Study Completion Date

October 7, 2022

Conditions
Malignant Pleural Effusion
Interventions
DRUG

Talc

All patients randomized to the Talc arm will receive Talc therapy through the pleural catheter.

Trial Locations (1)

27710

Duke University Medical Center, Durham

Sponsors

Lead Sponsor

Duke University
All Listed Sponsors
lead

Duke University

OTHER